drugset / Trial / NCT00666679

Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)

NCT00666679

Phase 2 Completed 134 enrolled Organon and Co
RandomizedCrossoverDouble-blindTreatment

Summary

This study assesses inhaled corticosteroid plus montelukast compared with inhaled corticosteroid therapy alone for treatment of patients with chronic asthma.

Timeline

Start
2008-05
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 1 mg Inhaled
Comparator Mometasone Other / unclassified 220 ug Inhaled

Indications